Global Ophthalmic Medicine Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Ophthalmic Medicine will have significant change from previous year. By the most conservative estimates of global Ophthalmic Medicine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Ophthalmic Medicine market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Medicine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Ophthalmic Medicine, covering the supply chain analysis, impact assessment to the Ophthalmic Medicine market size growth rate in several scenarios, and the measures to be undertaken by Ophthalmic Medicine companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Eye Drops
Eye Ointment
Gelling Agent
Tablet
Injection
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Anti-fatigue and Dryness
Cataract
Anti-infective
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novaliq
Shenyang Xingqi Pharmaceutical Co.,Ltd.
Chengdu Kanghong Pharmaceutical Group
Santen Pharmaceutica
Zhejiang Shapuaisi Pharmaceutical
Mentholatum
Bausch Health
Alcon NV
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Ophthalmic Medicine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Ophthalmic Medicine market by identifying its various subsegments.
Focuses on the key global Ophthalmic Medicine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Ophthalmic Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Ophthalmic Medicine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Ophthalmic Medicine?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Ophthalmic Medicine Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ophthalmic Medicine Consumption 2015-2025
2.1.2 Ophthalmic Medicine Consumption CAGR by Region
2.2 Ophthalmic Medicine Segment by Type
2.2.1 Eye Drops
2.2.2 Eye Ointment
2.2.3 Gelling Agent
2.2.4 Tablet
2.2.5 Injection
2.3 Ophthalmic Medicine Consumption by Type
2.3.1 Global Ophthalmic Medicine Consumption Market Share by Type (2015-2020)
2.3.2 Global Ophthalmic Medicine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Ophthalmic Medicine Sale Price by Type (2015-2020)
2.4 Ophthalmic Medicine Segment by Application
2.4.1 Anti-fatigue and Dryness
2.4.2 Cataract
2.4.3 Anti-infective
2.5 Ophthalmic Medicine Consumption by Application
2.5.1 Global Ophthalmic Medicine Consumption Market Share by Type (2015-2020)
2.5.2 Global Ophthalmic Medicine Value and Market Share by Type (2015-2020)
2.5.3 Global Ophthalmic Medicine Sale Price by Type (2015-2020)
3 Global Ophthalmic Medicine by Company
3.1 Global Ophthalmic Medicine Sales Market Share by Company
3.1.1 Global Ophthalmic Medicine Sales by Company (2018-2020)
3.1.2 Global Ophthalmic Medicine Sales Market Share by Company (2018-2020)
3.2 Global Ophthalmic Medicine Revenue Market Share by Company
3.2.1 Global Ophthalmic Medicine Revenue by Company (2018-2020)
3.2.2 Global Ophthalmic Medicine Revenue Market Share by Company (2018-2020)
3.3 Global Ophthalmic Medicine Sale Price by Company
3.4 Global Ophthalmic Medicine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Ophthalmic Medicine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Ophthalmic Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Ophthalmic Medicine by Regions
4.1 Ophthalmic Medicine by Regions
4.2 Americas Ophthalmic Medicine Consumption Growth
4.3 APAC Ophthalmic Medicine Consumption Growth
4.4 Europe Ophthalmic Medicine Consumption Growth
4.5 Middle East & Africa Ophthalmic Medicine Consumption Growth
5 Americas
5.1 Americas Ophthalmic Medicine Consumption by Countries
5.1.1 Americas Ophthalmic Medicine Consumption by Countries (2015-2020)
5.1.2 Americas Ophthalmic Medicine Value by Countries (2015-2020)
5.2 Americas Ophthalmic Medicine Consumption by Type
5.3 Americas Ophthalmic Medicine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Ophthalmic Medicine Consumption by Regions
6.1.1 APAC Ophthalmic Medicine Consumption by Regions (2015-2020)
6.1.2 APAC Ophthalmic Medicine Value by Regions (2015-2020)
6.2 APAC Ophthalmic Medicine Consumption by Type
6.3 APAC Ophthalmic Medicine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Ophthalmic Medicine by Countries
7.1.1 Europe Ophthalmic Medicine Consumption by Countries (2015-2020)
7.1.2 Europe Ophthalmic Medicine Value by Countries (2015-2020)
7.2 Europe Ophthalmic Medicine Consumption by Type
7.3 Europe Ophthalmic Medicine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Ophthalmic Medicine by Countries
8.1.1 Middle East & Africa Ophthalmic Medicine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Ophthalmic Medicine Value by Countries (2015-2020)
8.2 Middle East & Africa Ophthalmic Medicine Consumption by Type
8.3 Middle East & Africa Ophthalmic Medicine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Ophthalmic Medicine Distributors
10.3 Ophthalmic Medicine Customer
11 Global Ophthalmic Medicine Market Forecast
11.1 Global Ophthalmic Medicine Consumption Forecast (2021-2025)
11.2 Global Ophthalmic Medicine Forecast by Regions
11.2.1 Global Ophthalmic Medicine Forecast by Regions (2021-2025)
11.2.2 Global Ophthalmic Medicine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Ophthalmic Medicine Forecast by Type
11.8 Global Ophthalmic Medicine Forecast by Application
12 Key Players Analysis
12.1 Novaliq
12.1.1 Company Information
12.1.2 Ophthalmic Medicine Product Offered
12.1.3 Novaliq Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Novaliq Latest Developments
12.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
12.2.1 Company Information
12.2.2 Ophthalmic Medicine Product Offered
12.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Latest Developments
12.3 Chengdu Kanghong Pharmaceutical Group
12.3.1 Company Information
12.3.2 Ophthalmic Medicine Product Offered
12.3.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
12.4 Santen Pharmaceutica
12.4.1 Company Information
12.4.2 Ophthalmic Medicine Product Offered
12.4.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Santen Pharmaceutica Latest Developments
12.5 Zhejiang Shapuaisi Pharmaceutical
12.5.1 Company Information
12.5.2 Ophthalmic Medicine Product Offered
12.5.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Zhejiang Shapuaisi Pharmaceutical Latest Developments
12.6 Mentholatum
12.6.1 Company Information
12.6.2 Ophthalmic Medicine Product Offered
12.6.3 Mentholatum Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mentholatum Latest Developments
12.7 Bausch Health
12.7.1 Company Information
12.7.2 Ophthalmic Medicine Product Offered
12.7.3 Bausch Health Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Bausch Health Latest Developments
12.8 Alcon NV
12.8.1 Company Information
12.8.2 Ophthalmic Medicine Product Offered
12.8.3 Alcon NV Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Alcon NV Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Ophthalmic Medicine Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Ophthalmic Medicine Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Ophthalmic Medicine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Eye Drops
Table 7. Major Players of Eye Ointment
Table 8. Major Players of Gelling Agent
Table 9. Major Players of Tablet
Table 10. Major Players of Injection
Table 11. Global Consumption Sales by Type (2015-2020)
Table 12. Global Ophthalmic Medicine Consumption Market Share by Type (2015-2020)
Table 13. Global Ophthalmic Medicine Revenue by Type (2015-2020) ($ million)
Table 14. Global Ophthalmic Medicine Value Market Share by Type (2015-2020) ($ Millions)
Table 15. Global Ophthalmic Medicine Sale Price by Type (2015-2020)
Table 16. Global Consumption Sales by Application (2015-2020)
Table 17. Global Ophthalmic Medicine Consumption Market Share by Application (2015-2020)
Table 18. Global Ophthalmic Medicine Value by Application (2015-2020)
Table 19. Global Ophthalmic Medicine Value Market Share by Application (2015-2020)
Table 20. Global Ophthalmic Medicine Sale Price by Application (2015-2020)
Table 21. Global Ophthalmic Medicine Sales by Company (2017-2019) (K Units)
Table 22. Global Ophthalmic Medicine Sales Market Share by Company (2017-2019)
Table 23. Global Ophthalmic Medicine Revenue by Company (2017-2019) ($ Millions)
Table 24. Global Ophthalmic Medicine Revenue Market Share by Company (2017-2019)
Table 25. Global Ophthalmic Medicine Sale Price by Company (2017-2019)
Table 26. Global Ophthalmic Medicine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 27. Players Ophthalmic Medicine Products Offered
Table 28. Ophthalmic Medicine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 29. Global Ophthalmic Medicine Consumption by Regions 2015-2020 (K Units)
Table 30. Global Ophthalmic Medicine Consumption Market Share by Regions 2015-2020
Table 31. Global Ophthalmic Medicine Value by Regions 2015-2020 ($ Millions)
Table 32. Global Ophthalmic Medicine Value Market Share by Regions 2015-2020
Table 33. Americas Ophthalmic Medicine Consumption by Countries (2015-2020) (K Units)
Table 34. Americas Ophthalmic Medicine Consumption Market Share by Countries (2015-2020)
Table 35. Americas Ophthalmic Medicine Value by Countries (2015-2020) ($ Millions)
Table 36. Americas Ophthalmic Medicine Value Market Share by Countries (2015-2020)
Table 37. Americas Ophthalmic Medicine Consumption by Type (2015-2020) (K Units)
Table 38. Americas Ophthalmic Medicine Consumption Market Share by Type (2015-2020)
Table 39. Americas Ophthalmic Medicine Consumption by Application (2015-2020) (K Units)
Table 40. Americas Ophthalmic Medicine Consumption Market Share by Application (2015-2020)
Table 41. APAC Ophthalmic Medicine Consumption by Countries (2015-2020) (K Units)
Table 42. APAC Ophthalmic Medicine Consumption Market Share by Countries (2015-2020)
Table 43. APAC Ophthalmic Medicine Value by Regions (2015-2020) ($ Millions)
Table 44. APAC Ophthalmic Medicine Value Market Share by Regions (2015-2020)
Table 45. APAC Ophthalmic Medicine Consumption by Type (2015-2020) (K Units)
Table 46. APAC Ophthalmic Medicine Consumption Market Share by Type (2015-2020)
Table 47. APAC Ophthalmic Medicine Consumption by Application (2015-2020) (K Units)
Table 48. APAC Ophthalmic Medicine Consumption Market Share by Application (2015-2020)
Table 49. Europe Ophthalmic Medicine Consumption by Countries (2015-2020) (K Units)
Table 50. Europe Ophthalmic Medicine Consumption Market Share by Countries (2015-2020)
Table 51. Europe Ophthalmic Medicine Value by Countries (2015-2020) ($ Millions)
Table 52. Europe Ophthalmic Medicine Value Market Share by Countries (2015-2020)
Table 53. Europe Ophthalmic Medicine Consumption by Type (2015-2020) (K Units)
Table 54. Europe Ophthalmic Medicine Consumption Market Share by Type (2015-2020)
Table 55. Europe Ophthalmic Medicine Consumption by Application (2015-2020) (K Units)
Table 56. Europe Ophthalmic Medicine Consumption Market Share by Application (2015-2020)
Table 57. Middle East & Africa Ophthalmic Medicine Consumption by Countries (2015-2020) (K Units)
Table 58. Middle East & Africa Ophthalmic Medicine Consumption Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Ophthalmic Medicine Value by Countries (2015-2020) ($ Millions)
Table 60. Middle East & Africa Ophthalmic Medicine Value Market Share by Countries (2015-2020)
Table 61. Middle East & Africa Ophthalmic Medicine Consumption by Type (2015-2020) (K Units)
Table 62. Middle East & Africa Ophthalmic Medicine Consumption Market Share by Type (2015-2020)
Table 63. Middle East & Africa Ophthalmic Medicine Consumption by Application (2015-2020) (K Units)
Table 64. Middle East & Africa Ophthalmic Medicine Consumption Market Share by Application (2015-2020)
Table 65. Ophthalmic Medicine Distributors List
Table 66. Ophthalmic Medicine Customer List
Table 67. Global Ophthalmic Medicine Consumption Forecast by Countries (2021-2025) (K Units)
Table 68. Global Ophthalmic Medicine Consumption Market Forecast by Regions
Table 69. Global Ophthalmic Medicine Value Forecast by Countries (2021-2025) ($ Millions)
Table 70. Global Ophthalmic Medicine Value Market Share Forecast by Regions
Table 71. Global Ophthalmic Medicine Consumption Forecast by Type (2021-2025) (K Units)
Table 72. Global Ophthalmic Medicine Consumption Market Share Forecast by Type (2021-2025)
Table 73. Global Ophthalmic Medicine Value Forecast by Type (2021-2025) ($ Millions)
Table 74. Global Ophthalmic Medicine Value Market Share Forecast by Type (2021-2025)
Table 75. Global Ophthalmic Medicine Consumption Forecast by Application (2021-2025) (K Units)
Table 76. Global Ophthalmic Medicine Consumption Market Share Forecast by Application (2021-2025)
Table 77. Global Ophthalmic Medicine Value Forecast by Application (2021-2025) ($ Millions)
Table 78. Global Ophthalmic Medicine Value Market Share Forecast by Application (2021-2025)
Table 79. Novaliq Product Offered
Table 80. Novaliq Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 81. Novaliq Main Business
Table 82. Novaliq Latest Developments
Table 83. Novaliq Basic Information, Company Total Revenue (in $ million), Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 84. Shenyang Xingqi Pharmaceutical Co.,Ltd. Product Offered
Table 85. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 86. Shenyang Xingqi Pharmaceutical Co.,Ltd. Main Business
Table 87. Shenyang Xingqi Pharmaceutical Co.,Ltd. Latest Developments
Table 88. Shenyang Xingqi Pharmaceutical Co.,Ltd. Basic Information, Company Total Revenue (in $ million), Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 89. Chengdu Kanghong Pharmaceutical Group Product Offered
Table 90. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 91. Chengdu Kanghong Pharmaceutical Group Main Business
Table 92. Chengdu Kanghong Pharmaceutical Group Latest Developments
Table 93. Chengdu Kanghong Pharmaceutical Group Basic Information, Company Total Revenue (in $ million), Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 94. Santen Pharmaceutica Product Offered
Table 95. Santen Pharmaceutica Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 96. Santen Pharmaceutica Main Business
Table 97. Santen Pharmaceutica Latest Developments
Table 98. Santen Pharmaceutica Basic Information, Company Total Revenue (in $ million), Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 99. Zhejiang Shapuaisi Pharmaceutical Product Offered
Table 100. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 101. Zhejiang Shapuaisi Pharmaceutical Main Business
Table 102. Zhejiang Shapuaisi Pharmaceutical Latest Developments
Table 103. Zhejiang Shapuaisi Pharmaceutical Basic Information, Company Total Revenue (in $ million), Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 104. Mentholatum Product Offered
Table 105. Mentholatum Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 106. Mentholatum Main Business
Table 107. Mentholatum Latest Developments
Table 108. Mentholatum Basic Information, Company Total Revenue (in $ million), Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 109. Bausch Health Product Offered
Table 110. Bausch Health Basic Information, Company Total Revenue (in $ million), Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 111. Bausch Health Main Business
Table 112. Bausch Health Latest Developments
Table 113. Bausch Health Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 114. Alcon NV Product Offered
Table 115. Alcon NV Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 116. Alcon NV Main Business
Table 117. Alcon NV Latest Developments
Table 118. Alcon NV Basic Information, Company Total Revenue (in $ million), Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Ophthalmic Medicine
Figure 2. Ophthalmic Medicine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Ophthalmic Medicine Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Ophthalmic Medicine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Eye Drops
Figure 7. Product Picture of Eye Ointment
Figure 8. Product Picture of Gelling Agent
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Injection
Figure 11. Global Ophthalmic Medicine Consumption Market Share by Type (2015-2020)
Figure 12. Global Ophthalmic Medicine Value Market Share by Type (2015-2020)
Figure 13. Ophthalmic Medicine Consumed in Anti-fatigue and Dryness
Figure 14. Global Ophthalmic Medicine Market: Anti-fatigue and Dryness (2015-2020) (K Units)
Figure 15. Global Ophthalmic Medicine Market: Anti-fatigue and Dryness (2015-2020) ($ Millions)
Figure 16. Ophthalmic Medicine Consumed in Cataract
Figure 17. Global Ophthalmic Medicine Market: Cataract (2015-2020) (K Units)
Figure 18. Global Ophthalmic Medicine Market: Cataract (2015-2020) ($ Millions)
Figure 19. Ophthalmic Medicine Consumed in Anti-infective
Figure 20. Global Ophthalmic Medicine Market: Anti-infective (2015-2020) (K Units)
Figure 21. Global Ophthalmic Medicine Market: Anti-infective (2015-2020) ($ Millions)
Figure 22. Global Ophthalmic Medicine Consumption Market Share by Application (2015-2020)
Figure 23. Global Ophthalmic Medicine Value Market Share by Application (2015-2020)
Figure 24. Global Ophthalmic Medicine Sales Market Share by Company in 2017
Figure 25. Global Ophthalmic Medicine Sales Market Share by Company in 2019
Figure 26. Global Ophthalmic Medicine Revenue Market Share by Company in 2017
Figure 27. Global Ophthalmic Medicine Revenue Market Share by Company in 2019
Figure 28. Global Ophthalmic Medicine Sale Price by Company in 2019
Figure 29. Global Ophthalmic Medicine Consumption Market Share by Regions 2015-2020
Figure 30. Global Ophthalmic Medicine Value Market Share by Regions 2015-2020
Figure 31. Americas Ophthalmic Medicine Consumption 2015-2020 (K Units)
Figure 32. Americas Ophthalmic Medicine Value 2015-2020 ($ Millions)
Figure 33. APAC Ophthalmic Medicine Consumption 2015-2020 (K Units)
Figure 34. APAC Ophthalmic Medicine Value 2015-2020 ($ Millions)
Figure 35. Europe Ophthalmic Medicine Consumption 2015-2020 (K Units)
Figure 36. Europe Ophthalmic Medicine Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Ophthalmic Medicine Consumption 2015-2020 (K Units)
Figure 38. Middle East & Africa Ophthalmic Medicine Value 2015-2020 ($ Millions)
Figure 39. Americas Ophthalmic Medicine Consumption Market Share by Countries in 2019
Figure 40. Americas Ophthalmic Medicine Value Market Share by Countries in 2019
Figure 41. Americas Ophthalmic Medicine Consumption Market Share by Type in 2019
Figure 42. Americas Ophthalmic Medicine Consumption Market Share by Application in 2019
Figure 43. United States Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 44. United States Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 46. Canada Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 48. Mexico Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Ophthalmic Medicine Consumption Market Share by Countries in 2019
Figure 50. APAC Ophthalmic Medicine Value Market Share by Regions in 2019
Figure 51. APAC Ophthalmic Medicine Consumption Market Share by Type in 2019
Figure 52. APAC Ophthalmic Medicine Consumption Market Share by Application in 2019
Figure 53. China Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 54. China Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 56. Japan Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 58. Korea Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 60. Southeast Asia Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 61. India Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 62. India Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 64. Australia Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Ophthalmic Medicine Consumption Market Share by Countries in 2019
Figure 66. Europe Ophthalmic Medicine Value Market Share by Countries in 2019
Figure 67. Europe Ophthalmic Medicine Consumption Market Share by Type in 2019
Figure 68. Europe Ophthalmic Medicine Consumption Market Share by Application in 2019
Figure 69. Germany Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 70. Germany Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 71. France Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 72. France Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 73. UK Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 74. UK Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 76. Italy Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 78. Russia Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Ophthalmic Medicine Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Ophthalmic Medicine Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Ophthalmic Medicine Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Ophthalmic Medicine Consumption Market Share by Application in 2019
Figure 83. Egypt Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 84. Egypt Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 86. South Africa Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 88. Israel Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 90. Turkey Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Ophthalmic Medicine Consumption Growth 2015-2020 (K Units)
Figure 92. GCC Countries Ophthalmic Medicine Value Growth 2015-2020 ($ Millions)
Figure 93. Global Ophthalmic Medicine Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 94. Global Ophthalmic Medicine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 96. Americas Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 97. APAC Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 98. APAC Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 99. Europe Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 100. Europe Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 102. Middle East & Africa Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 103. United States Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 104. United States Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 105. Canada Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 106. Canada Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 107. Mexico Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 108. Mexico Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 109. Brazil Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 110. Brazil Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 111. China Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 112. China Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 113. Japan Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 114. Japan Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 115. Korea Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 116. Korea Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 118. Southeast Asia Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 119. India Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 120. India Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 121. Australia Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 122. Australia Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 123. Germany Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 124. Germany Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 125. France Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 126. France Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 127. UK Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 128. UK Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 129. Italy Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 130. Italy Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 131. Russia Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 132. Russia Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 133. Spain Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 134. Spain Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 135. Egypt Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 136. Egypt Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 137. South Africa Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 138. South Africa Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 139. Israel Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 140. Israel Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 141. Turkey Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 142. Turkey Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Ophthalmic Medicine Consumption 2021-2025 (K Units)
Figure 144. GCC Countries Ophthalmic Medicine Value 2021-2025 ($ Millions)
Figure 145. Novaliq Ophthalmic Medicine Market Share (2018-2020)
Figure 146. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Market Share (2018-2020)
Figure 147. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Market Share (2018-2020)
Figure 148. Santen Pharmaceutica Ophthalmic Medicine Market Share (2018-2020)
Figure 149. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Market Share (2018-2020)
Figure 150. Mentholatum Ophthalmic Medicine Market Share (2018-2020)
Figure 151. Bausch Health Ophthalmic Medicine Market Share (2018-2020)
Figure 152. Alcon NV Ophthalmic Medicine Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets